Valuation: OrganiGram

Market Cap 204M 144M 126M 115M 108M 13.68B 207M 1.39B 539M 6.73B 539M 528M 23.18B P/E 2026 *
11.2x
P/E 2027 * 36.3x
Enterprise Value 204M 144M 126M 115M 108M 13.68B 207M 1.39B 539M 6.73B 539M 528M 23.18B EV / Sales 2026 *
0.6x
EV / Sales 2027 * 0.46x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 14/01/2026
Director of Finance/CFO - 07/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 28/03/2018
Director/Board Member 56 16/12/2018
Director/Board Member 70 16/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 144M
+72.76%-.--%-39.25% - 578M
-2.01%+3.17%+53.54%+205.98% 223M
0.00%+8.93%+22.00%+103.33% 127M
0.00%-6.00%+46.88%-24.19% 95.4M
+4.47%-4.14%+45.28%-2.60% 92.84M
-0.79%+2.59%-36.59%-47.77% 59.26M
Average +10.08%+3.11%+15.31%+46.95% 195.91M
Weighted average by Cap. +31.39%+2.33%-1.23%+89.81%

Financials

2026 *2027 *
Net sales 340M 239M 209M 192M 179M 22.76B 345M 2.31B 896M 11.19B 897M 878M 38.56B 441M 310M 271M 249M 232M 29.55B 447M 2.99B 1.16B 14.53B 1.16B 1.14B 50.05B
Net income 18.88M 13.29M 11.62M 10.68M 9.95M 1.27B 19.16M 128M 49.83M 622M 49.89M 48.81M 2.14B 6.53M 4.6M 4.02M 3.69M 3.44M 438M 6.63M 44.34M 17.24M 215M 17.26M 16.89M 741M
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-